{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:09:19Z","timestamp":1783948159684,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the second batch of Zhaoyang Talent Project of Affiliated Hospital of Shandong University of Traditional Chinese Medicine","award":["rc2021003-17"],"award-info":[{"award-number":["rc2021003-17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01347-7","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:42:30Z","timestamp":1768632150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chebulagic acid targets FBXO38 to enhance natural killer cell-mediated anti-tumor immunity in lung adenocarcinoma"],"prefix":"10.1007","volume":"39","author":[{"given":"Xiwen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiran","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5523-5312","authenticated-orcid":false,"given":"Xiaoqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"6","key":"1347_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"1347_CR2","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","volume":"8","author":"J Qi","year":"2023","unstructured":"Qi J, Li M, Wang L, Hu Y, Liu W, Long Z, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8(12):e943\u201355. https:\/\/doi.org\/10.1016\/S2468-2667(23)00211-6.","journal-title":"Lancet Public Health"},{"issue":"1","key":"1347_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41768-8","volume":"14","author":"E Moreo","year":"2023","unstructured":"Moreo E, Jarit-Cabanillas A, Robles-Vera I, Uranga S, Guerrero C, Gomez AB, et al. Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung. Nat Commun. 2023;14(1):6090. https:\/\/doi.org\/10.1038\/s41467-023-41768-8.","journal-title":"Nat Commun"},{"key":"1347_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1051998","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Li S, Li C, Li T, Huang Y. Remodeling tumor microenvironment with natural products to overcome drug resistance. Front Immunol. 2022;13:1051998. https:\/\/doi.org\/10.3389\/fimmu.2022.1051998.","journal-title":"Front Immunol"},{"issue":"3","key":"1347_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semradonc.2010.01.003","volume":"20","author":"EE Graves","year":"2010","unstructured":"Graves EE, Maity A, Le QT. The tumor microenvironment in non-small-cell lung cancer. Semin Radiat Oncol. 2010;20(3):156\u201363. https:\/\/doi.org\/10.1016\/j.semradonc.2010.01.003.","journal-title":"Semin Radiat Oncol"},{"key":"1347_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells11040605","author":"E Russell","year":"2022","unstructured":"Russell E, Conroy MJ, Barr MP. Harnessing natural killer cells in non-small cell lung cancer. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11040605.","journal-title":"Cells"},{"issue":"1","key":"1347_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14712598.2020.1688298","volume":"20","author":"AG Pockley","year":"2020","unstructured":"Pockley AG, Vaupel P, Multhoff G. NK cell-based therapeutics for lung cancer. Expert Opin Biol Ther. 2020;20(1):23\u201333. https:\/\/doi.org\/10.1080\/14712598.2020.1688298.","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"1347_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","volume":"23","author":"NK Wolf","year":"2023","unstructured":"Wolf NK, Kissiov DU, Raulet DH. Roles of natural killer cells in immunity to cancer, and applications to immunotherapy. Nat Rev Immunol. 2023;23(2):90\u2013105. https:\/\/doi.org\/10.1038\/s41577-022-00732-1.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1347_CR9","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","volume":"169","author":"Y Lavin","year":"2017","unstructured":"Lavin Y, Kobayashi S, Leader A, Amir ED, Elefant N, Bigenwald C, et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses. Cell. 2017;169(4):750-65e17. https:\/\/doi.org\/10.1016\/j.cell.2017.04.014.","journal-title":"Cell"},{"key":"1347_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114323","volume":"278","author":"Z Wang","year":"2021","unstructured":"Wang Z, Xu J, Wang Y, Xiang L, He X. Total saponins from Tupistra chinensis baker inhibits growth of human gastric cancer cells in vitro and in vivo. J Ethnopharmacol. 2021;278:114323. https:\/\/doi.org\/10.1016\/j.jep.2021.114323.","journal-title":"J Ethnopharmacol"},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mvr.2018.09.001","volume":"121","author":"S Shanmuganathan","year":"2019","unstructured":"Shanmuganathan S, Angayarkanni N. Chebulagic acid and Chebulinic acid inhibit TGF-\u03b21 induced fibrotic changes in the chorio-retinal endothelial cells by inhibiting ERK phosphorylation. Microvasc Res. 2019;121:14\u201323. https:\/\/doi.org\/10.1016\/j.mvr.2018.09.001.","journal-title":"Microvasc Res"},{"issue":"9","key":"1347_CR12","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1080\/07391102.2022.2060862","volume":"41","author":"DP Yeggoni","year":"2023","unstructured":"Yeggoni DP, Meti M, Subramanyam R. Chebulinic and chebulagic acid binding with serum proteins: biophysical and molecular docking approach. J Biomol Struct Dyn. 2023;41(9):4024\u201339. https:\/\/doi.org\/10.1080\/07391102.2022.2060862.","journal-title":"J Biomol Struct Dyn"},{"key":"1347_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1427632","volume":"14","author":"B Shreevatsa","year":"2024","unstructured":"Shreevatsa B, Hegde S, Narayan P, Dharmashekar C, Jain A, Wani TA, et al. Targeting FAK, VEGF, and MTA1 proteins with Terminalia elliptica: a computational approach for anticancer activity. Front Oncol. 2024;14:1427632. https:\/\/doi.org\/10.3389\/fonc.2024.1427632.","journal-title":"Front Oncol"},{"key":"1347_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep09642","volume":"5","author":"K Lu","year":"2015","unstructured":"Lu K, Basu S. The natural compound chebulagic acid inhibits vascular endothelial growth factor A mediated regulation of endothelial cell functions. Sci Rep. 2015;5:9642. https:\/\/doi.org\/10.1038\/srep09642.","journal-title":"Sci Rep"},{"key":"1347_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1143427","volume":"14","author":"J Zhao","year":"2023","unstructured":"Zhao J, Shi Y, Ma Y, Pan L, Wang Y, Yuan L, et al. Chebulagic acid suppresses gastric cancer by inhibiting the AURKA\/\u03b2-catenin\/Wnt pathway. Front Pharmacol. 2023;14:1143427. https:\/\/doi.org\/10.3389\/fphar.2023.1143427.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1347_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jep.2009.05.022","volume":"124","author":"DB Reddy","year":"2009","unstructured":"Reddy DB, Reddy TC, Jyotsna G, Sharan S, Priya N, Lakshmipathi V, et al. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J Ethnopharmacol. 2009;124(3):506\u201312. https:\/\/doi.org\/10.1016\/j.jep.2009.05.022.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1347_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2044103","volume":"11","author":"H Xiong","year":"2022","unstructured":"Xiong H, Xi Y, Yuan Z, Wang B, Hu S, Fang C, et al. IFN-\u03b3 activates the tumor cell-intrinsic STING pathway through the induction of DNA damage and cytosolic dsDNA formation. Oncoimmunology. 2022;11(1):2044103. https:\/\/doi.org\/10.1080\/2162402X.2022.2044103.","journal-title":"Oncoimmunology"},{"issue":"11","key":"1347_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113362","volume":"42","author":"T Tian","year":"2023","unstructured":"Tian T, Xie X, Yi W, Zhou Y, Xu Y, Wang Z, et al. FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation. Cell Rep. 2023;42(11):113362. https:\/\/doi.org\/10.1016\/j.celrep.2023.113362.","journal-title":"Cell Rep"},{"key":"1347_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.100973","volume":"49","author":"Y Wu","year":"2024","unstructured":"Wu Y, Lin Y, Shen F, Huang R, Zhang Z, Zhou M, et al. FBXO38 deficiency promotes lysosome-dependent STING degradation and inhibits cGAS-STING pathway activation. Neoplasia. 2024;49:100973. https:\/\/doi.org\/10.1016\/j.neo.2024.100973.","journal-title":"Neoplasia"},{"key":"1347_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1177847","volume":"14","author":"J Shu","year":"2023","unstructured":"Shu J, Jiang J, Zhao G. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. Front Immunol. 2023;14:1177847. https:\/\/doi.org\/10.3389\/fimmu.2023.1177847.","journal-title":"Front Immunol"},{"issue":"10","key":"1347_CR21","first-page":"993","volume":"81","author":"SJ Bott","year":"1986","unstructured":"Bott SJ, Hanks JB, Stone DD. Solitary hamartomatous polyp of the duodenum in the absence of familial polyposis. Am J Gastroenterol. 1986;81(10):993\u20134.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1347_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s43440-019-00023-y","volume":"72","author":"M Mehrabani","year":"2020","unstructured":"Mehrabani M, Goudarzi M, Mehrzadi S, Siahpoosh A, Mohammadi M, Khalili H, et al. Crocin: a protective natural antioxidant against pulmonary fibrosis induced by bleomycin. Pharmacol Rep. 2020;72(4):992\u20131001. https:\/\/doi.org\/10.1007\/s43440-019-00023-y.","journal-title":"Pharmacol Rep"},{"key":"1347_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2024.149983","volume":"718","author":"S Huang","year":"2024","unstructured":"Huang S, Zhao H, Lou X, Chen D, Shi C, Ren Z. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K\/AKT\/mtor pathway. Biochem Biophys Res Commun. 2024;718:149983. https:\/\/doi.org\/10.1016\/j.bbrc.2024.149983.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1347_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48307-x","volume":"14","author":"J Wang","year":"2024","unstructured":"Wang J, Dong L, Zheng Z, Zhu Z, Xie B, Xie Y, et al. Effects of different KRAS mutants and Ki67 expression on diagnosis and prognosis in lung adenocarcinoma. Sci Rep. 2024;14(1):4085. https:\/\/doi.org\/10.1038\/s41598-023-48307-x.","journal-title":"Sci Rep"},{"issue":"1","key":"1347_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12022-023-09755-3","volume":"34","author":"S La Rosa","year":"2023","unstructured":"La Rosa S. Diagnostic, prognostic, and predictive role of Ki67 proliferative index in neuroendocrine and endocrine neoplasms: past, present, and future. Endocr Pathol. 2023;34(1):79\u201397. https:\/\/doi.org\/10.1007\/s12022-023-09755-3.","journal-title":"Endocr Pathol"},{"key":"1347_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7761589","volume":"2022","author":"W Yao","year":"2022","unstructured":"Yao W, Liao Y, Li X, Zhang F, Zhang H, Hu B, et al. Noninvasive method for predicting the expression of Ki67 and prognosis in non-small-cell lung cancer patients: radiomics. J Healthc Eng. 2022;2022:7761589. https:\/\/doi.org\/10.1155\/2022\/7761589.","journal-title":"J Healthc Eng"},{"issue":"6","key":"1347_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189024","volume":"1878","author":"A Gielecinska","year":"2023","unstructured":"Gielecinska A, Kciuk M, Yahya EB, Ainane T, Mujwar S, Kontek R. Apoptosis, necroptosis, and pyroptosis as alternative cell death pathways induced by chemotherapeutic agents? Biochim Biophys Acta Rev Cancer. 2023;1878(6):189024. https:\/\/doi.org\/10.1016\/j.bbcan.2023.189024.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"10","key":"1347_CR28","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1007\/s12035-023-03433-5","volume":"60","author":"G Sahoo","year":"2023","unstructured":"Sahoo G, Samal D, Khandayataray P, Murthy MK. A review on caspases: key regulators of biological activities and apoptosis. Mol Neurobiol. 2023;60(10):5805\u201337. https:\/\/doi.org\/10.1007\/s12035-023-03433-5.","journal-title":"Mol Neurobiol"},{"key":"1347_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1442737","volume":"14","author":"Y Cho","year":"2024","unstructured":"Cho Y, Park MN, Choi M, Upadhyay TK, Kang HN, Oh JM, et al. Sulforaphane regulates cell proliferation and induces apoptotic cell death mediated by ROS-cell cycle arrest in pancreatic cancer cells. Front Oncol. 2024;14:1442737. https:\/\/doi.org\/10.3389\/fonc.2024.1442737.","journal-title":"Front Oncol"},{"issue":"11","key":"1347_CR30","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/1873-3468.14864","volume":"598","author":"SS Kim","year":"2024","unstructured":"Kim SS, Seo SR. Caspase-3 targets pro-interleukin-1beta (IL-1beta) to restrict inflammation. FEBS Lett. 2024;598(11):1366\u201374. https:\/\/doi.org\/10.1002\/1873-3468.14864.","journal-title":"FEBS Lett"},{"key":"1347_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094666","author":"JW Lin","year":"2022","unstructured":"Lin JW, Lin YC, Liu JM, Liu SH, Fang KM, Hsu RJ, et al. Norketamine, the main metabolite of ketamine, induces mitochondria-dependent and ER stress-triggered apoptotic death in urothelial cells via a Ca(2+)-regulated ERK1\/2-activating pathway. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23094666.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1347_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","volume":"24","author":"KC Barry","year":"2018","unstructured":"Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, et al. A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments. Nat Med. 2018;24(8):1178\u201391. https:\/\/doi.org\/10.1038\/s41591-018-0085-8.","journal-title":"Nat Med"},{"key":"1347_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cytogfr.2020.12.003","volume":"59","author":"X Yao","year":"2021","unstructured":"Yao X, Matosevic S. Chemokine networks modulating natural killer cell trafficking to solid tumors. Cytokine Growth Factor Rev. 2021;59:36\u201345. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.12.003.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"1347_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0319-1","volume":"9","author":"S Hou","year":"2018","unstructured":"Hou S, Tian T, Qi D, Sun K, Yuan Q, Wang Z, et al. S100A4 promotes lung tumor development through \u03b2-catenin pathway-mediated autophagy inhibition. Cell Death Dis. 2018;9(3):277. https:\/\/doi.org\/10.1038\/s41419-018-0319-1.","journal-title":"Cell Death Dis"},{"key":"1347_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.799759","volume":"11","author":"ZX Wu","year":"2021","unstructured":"Wu ZX, Huang X, Cai MJ, Huang PD, Guan Z. Development and validation of a prognostic index based on genes participating in autophagy in patients with lung adenocarcinoma. Front Oncol. 2021;11:799759. https:\/\/doi.org\/10.3389\/fonc.2021.799759.","journal-title":"Front Oncol"},{"issue":"44","key":"1347_CR36","doi-asserted-by":"publisher","first-page":"E9271","DOI":"10.1073\/pnas.1703921114","volume":"114","author":"T Mgrditchian","year":"2017","unstructured":"Mgrditchian T, Arakelian T, Paggetti J, Noman MZ, Viry E, Moussay E, et al. Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner. Proc Natl Acad Sci USA. 2017;114(44):E9271\u20139. https:\/\/doi.org\/10.1073\/pnas.1703921114.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1347_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000131","author":"F Li","year":"2020","unstructured":"Li F, Sheng Y, Hou W, Sampath P, Byrd D, Thorne S, et al. CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2019-000131.","journal-title":"J Immunother Cancer"},{"issue":"8_Supplement","key":"1347_CR38","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1158\/1538-7445.am2013-4879","volume":"73","author":"D Bei","year":"2013","unstructured":"Bei D, Xie L, Lu K, Chan K, Basu S, Liu Z. Abstract 4879: determination of chebulagic acid and chebulinic acid and their pharmacokinetics in mouse. Cancer Res. 2013;73(8_Supplement):4879. https:\/\/doi.org\/10.1158\/1538-7445.am2013-4879.","journal-title":"Cancer Res"},{"issue":"2","key":"1347_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.it.2018.12.005","volume":"40","author":"TM Serman","year":"2019","unstructured":"Serman TM, Gack MU. FBXO38 drives PD-1 to destruction. Trends Immunol. 2019;40(2):81\u20133. https:\/\/doi.org\/10.1016\/j.it.2018.12.005.","journal-title":"Trends Immunol"},{"issue":"10","key":"1347_CR40","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/2326-6066.CIR-23-1061","volume":"12","author":"Y Shi","year":"2024","unstructured":"Shi Y, Zheng X, Peng H, Xu C, Sun R, Tian Z, et al. The E3 ubiquitin ligase FBXO38 maintains the antitumor function of natural killer cells by sustaining IL15R signaling. Cancer Immunol Res. 2024;12(10):1438\u201351. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-1061.","journal-title":"Cancer Immunol Res"},{"issue":"7734","key":"1347_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","volume":"564","author":"X Meng","year":"2018","unstructured":"Meng X, Liu X, Guo X, Jiang S, Chen T, Hu Z, et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. Nature. 2018;564(7734):130\u20135. https:\/\/doi.org\/10.1038\/s41586-018-0756-0.","journal-title":"Nature"},{"issue":"11","key":"1347_CR42","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41422-021-00543-4","volume":"31","author":"J Guo","year":"2021","unstructured":"Guo J, Liang Y, Xue D, Shen J, Cai Y, Zhu J, et al. Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity. Cell Res. 2021;31(11):1190\u20138. https:\/\/doi.org\/10.1038\/s41422-021-00543-4.","journal-title":"Cell Res"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01347-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:42:31Z","timestamp":1768632151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01347-7","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"18 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were performed following the National Research Council guide for the care and use of laboratory animals and approved by the institutional animal care and use committee at animal research center of Affiliated Hospital of Shandong University of Traditional Chinese Medicine (Approval ID 2024-108-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"36"}}